Horizon Investments, LLC Organon & Co. Transaction History

Horizon Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$17.45 - $21.96 $785 - $988	45 New	45 $0
Q3 2023 Nov 14, 2023	BUY	$16.59 - $23.77 $846 - $1,212	51 Added 0.96%	5,353 $92,000
Q2 2023 Aug 14, 2023	BUY	$19.27 - $24.63 $3,911 - $4,999	203 Added 3.98%	5,302 $110,000
Q1 2023 May 15, 2023	BUY	$21.42 - $32.08 $109,220 - $163,575	5,099 New	5,099 $119,000

790

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Horizon Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Horizon Investments, LLC with notifications on news.